InvestorsHub Logo

rolvram

02/06/19 8:36 AM

#14023 RE: simps #14017

Wwll said!

"Amazing potential, wonder if people actually realizes what’s about to happen with this, yet, small CBD company. Not only have we seen tremendous revenue growth from their CBD line of products but the addition of the SAM’s units attacks a whole new market; personal injury usage paid for by no fault insurance. The company says that one unit is expected to bring in $14k/year, 100 units would be $1.4M – that alone is, in my estimation, is more than all revenues for 2018. The commitment calls for 1,650 units in 2018 – 1,650 x $14k = $23M so if they order zero units in 2020 we can expect $23M in Revenue that year. This year should come in around $12M based on their monthly commitments, over 10 times 2018 Revenue (my estimate). That’s GROWTH! And this is only the SAM’s units, not counting CBD product sales. In my humble opinion that 10x growth, everything else being equal, should have the potential to grow the stock price 10x but even 5x (if one assumes dilution from capital raise etc) would give us a stock price of 8 cents x 5 = $0.40.
Last year the company also announced a slew of new manufacturing equipment so I would expect to see an expanded product line as this equipment get online (probably needs certification which takes some time). This new equipment not only increases the output capacity and efficiency in manufacturing but also should have excess capacity to increase private label production.
Lastly, the teams assembled in this company are getting more and more impressive from doctors with vast background and strong reputations to other professionals with government experience (ex-senator) to attorney with personal injury/no fault experience and TEN’s units/pads (Mobius) background.
Nothing is perfect and as the company moves forward I’m sure there will be growth issues, but from my vantage point this winning formula will be hard to mess up. I also see the company as a potential take-over candidate by another, larger, public entity that wants the Revenue (potential) and recognizes what that will do to its own market cap and market coverage.
The above just my opinion, do your due diligence, but I remain VERY bullish and believe the current stock price is extremely cheap when I gaze into my crystal ball"

AgSEC

02/06/19 2:52 PM

#14054 RE: simps #14017

Great post simps. Really expresses the growth here. This is not potential growth. This is actual growth.

sleekscape

02/07/19 12:30 PM

#14087 RE: simps #14017

This is an outstanding post

Thank you for sharing your perspective

It provides an excellent perspective on why CANB’s business model is unique in the CBD Oil subsector and why CANB has the potential to become a very special stock

Anything under .10 is significantly undervalued based on what has been announced thus far


Sleek

skyhawk66

02/07/19 1:16 PM

#14089 RE: simps #14017

Excellent Breakdown on the Actual Growth! No wonder Smart Money keeps buying Shares.

mr slam

03/11/19 5:45 AM

#14770 RE: simps #14017

RIGHT ON SIMPS!

AND PLEASE KNOW THAT THE SAMS UNIT PROJECTIONS ARE CONSERVATIVE AND DEMAND

IS FAR OUTPACING THE SUPPLY OF THEM NOW IN THE DISTRIBUTION CHANNEL-

AND YES THERE WILL BE BILLING AND RAMP UP FACTORS TO GET THE REVENUE STREAM

GOING BUT THAT IS THE SAME FOR ANYTHING ELSE THAT BUILDS ON A RECURRING

REVENUE MODEL......LOVE THE PROJECTIONS AND ESTIMATION! DEAD ON AND

WELL DONE!